Literature DB >> 7901282

Characterization of type I complement C2 deficiency MHC haplotypes. Strong conservation of the complotype/HLA-B-region and absence of disease association due to linked class II genes.

L Truedsson1, C A Alper, Z L Awdeh, P Johansen, A G Sjöholm, G Sturfelt.   

Abstract

Fourteen individuals with complete C2 deficiency from 11 families and 3 heterozygous C2-deficient individuals from two families were investigated. In all the 24 independent C2-deficient haplotypes, the complotype S042 was present and the majority (21/24) was [HLA-B18,S042,DR2]. All carried the type I C2 deficiency C2 pseudogene with its characteristic 28 bp deletion. All but two haplotypes had 10 AC/GT repeats in the TNF alpha microsatellite polymorphism and all but one of the haplotypes were identical at or near HLA-B as assessed by RFLP using BstEII digestion and two genomic probes, R5A and M20A, located 100 and 38 kb centromeric to HLA-B, respectively. The exceptional haplotype was HLA-B40 with four AC/GT repeats at TNF-alpha. Three of the haplotypes were not DR2 based on generic and sequence-specific oligonucleotide typing. Another four haplotypes showed different DO-variants detected by RFLP analysis using BglIIand Mspl digestion. Thus, the [HLA-B18,S042,DR2] haplotype appears to be more fixed in the region between the complement genes and the HLA-B locus (96%) than in the region between the complement genes and DR (88%) and DO loci (71%). Of the 14 individuals studied, six had SLE or SLE-like syndromes and six had a history of severe infections although two were apparently healthy. Three of the six SLE patients and two individuals with repeated infections were homozygous for [HLA-B18,S042,DR2] and also homozygous for DQB1*0602 and the common DO variant. Thus, MHC class II genes linked to the C2 pseudogene do not appear to determine different clinical consequences of C2 deficiency.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901282

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Vaccination responses to capsular polysaccharides of Neisseria meningitidis and Haemophilus influenzae type b in two C2-deficient sisters: alternative pathway-mediated bacterial killing and evidence for a novel type of blocking IgG.

Authors:  B Selander; H Käyhty; E Wedege; E Holmström; L Truedsson; C Söderström; A G Sjöholm
Journal:  J Clin Immunol       Date:  2000-03       Impact factor: 8.317

2.  Combined heterozygous deficiency of the classical complement pathway proteins C2 and C4.

Authors:  D Hartmann; V Fremeaux-Bacchi; L Weiss; A Meyer; J Blouin; G Hauptmann; M Kazatchkine; B Uring-Lambert
Journal:  J Clin Immunol       Date:  1997-03       Impact factor: 8.317

3.  Molecular heterogeneity in deficiency of complement protein C2 type I.

Authors:  X Wang; A Circolo; M L Lokki; P G Shackelford; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

4.  Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency.

Authors:  Chester A Alper; Jianhua Xu; Katherine Cosmopoulos; Brian Dolinski; Rosanne Stein; Gabriel Uko; Charles E Larsen; Devendra P Dubey; Peter Densen; Lennart Truedsson; Gunnar Sturfelt; Anders G Sjöholm
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

5.  Recombinant human complement component C2 produced in a human cell line restores the classical complement pathway activity in-vitro: an alternative treatment for C2 deficiency diseases.

Authors:  Paolo G V Martini; Lynette C Cook; Scott Alderucci; Angela W Norton; Dianna M Lundberg; Susan M Fish; Knut Langsetmo; Göran Jönsson; Christian Lood; Birgitta Gullstrand; Kate J Zaleski; Nancy Savioli; Jason Lottherand; Charles Bedard; John Gill; Michael F Concino; Michael W Heartlein; Lennart Truedsson; Jan L Powell; Arthur O Tzianabos
Journal:  BMC Immunol       Date:  2010-08-20       Impact factor: 3.615

6.  Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Natalia Umetsu; Adriana A Jesus; Silvia Y Bando; Clovis A Silva; Magda Carneiro-Sampaio
Journal:  Clinics (Sao Paulo)       Date:  2015-03-01       Impact factor: 2.365

7.  Dominant sequences of human major histocompatibility complex conserved extended haplotypes from HLA-DQA2 to DAXX.

Authors:  Charles E Larsen; Dennis R Alford; Michael R Trautwein; Yanoh K Jalloh; Jennifer L Tarnacki; Sushruta K Kunnenkeri; Dolores A Fici; Edmond J Yunis; Zuheir L Awdeh; Chester A Alper
Journal:  PLoS Genet       Date:  2014-10-09       Impact factor: 5.917

Review 8.  Current status of lupus genetics.

Authors:  Andrea L Sestak; Swapan K Nath; Amr H Sawalha; John B Harley
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.